Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients

Clinical Biochemistry

Volumn 47, Issue 12, 2014, Pages 1015-1021

  Novotny, Dalibor ^a   Vaverkova, Helena ^b   Karasek, David ^b   Malina, Pavel ^c  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c Hospital Písek   (Czech Republic)

Author keywords

Apolipoprotein A5; Apolipoprotein E; Dyslipidemia; Genetic polymorphism; Metabolic syndrome; Triglycerides

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; GENETICS; MIDDLE AGED;

ADULT; APOLIPOPROTEINS A; APOLIPOPROTEINS E; DYSLIPIDEMIAS; FEMALE; GENE FREQUENCY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 84905729518     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.03.015     Document Type: Article

References (38)

1. Eckel R.H., Grundy S.M., Zimment P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
2. Bosy-Westphal A., Onur S., Geisler C., Wolf A., Korth O., Pfeufferm M., et al. Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study. Int J Obes (Lond) 2007, 31:784-790.
3. Henneman P., Aulchenko Y.S., Frants R.R., van Dijk K.W., Oostra B.A., van Duijn C.M. Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 2008, 45:572-577.
4. Teran-Garcia M., Bouchard C. Genetics of the metabolic syndrome. Appl Physiol Nutr Metab 2007, 32:89-114.
5. Povel C.M., Boer J.M.A., Imholz S., Dollé M.E.T., Feskens E.J.M. Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome. Lipids Health Dis 2011, 10:118. [ ://www.lipidworld.com/content/10/1/118].
6. Hubacek J.A., Skodova Z., Adamkova V., Lanska V., Poledne R. The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 2004, 65:126-130.
7. Talmud P.J., Hawe E., Martin S., Olivier M., Miller G., Rubin E., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002, 11:3039-3046.
8. Johansen C.T., Kathiresan S., Hegele R.A. Genetic determinants of plasma triglycerides. J Lipid Res 2011, 52:189-206.
9. Sharma V., Ryan R.O., Forte T.M. Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement. Biochim Biophys Acta 1821, 2012:795-799.
10. Yamada Y., Kato K., Hibino T., Yokoi H., Matsuo T., Segawa S., et al. Prediction of genetic risk for metabolic syndrome. Atherosclerosis 2007, 191:298-304.
11. Grallert H., Sedlmeier E.M., Huth C., Kolz M., Heid I.M., Meisinger Ch., et al. APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res 2007, 48:2614-2621.
12. Maasz A., Kisfali P., Horvatovich K., Mohas M., Marko L., Csongei V., et al. Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathol Oncol Res 2007, 13:243-247.
13. Ong K.L., Jiang C.Q., Liu B., Tso A.W.K., Tam S., Wong K.S., et al. Association of a genetic variant in the apolipoprotein A5 gene with the metabolic syndrome in Chinese. Clin Endocrinol 2011, 74:206-213.
14. Garelnabi M., Lor K., Jin J., Chai F., Santanam N. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem 2013, 46:12-19.
15. Zaki M., Amr K. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents. Gene 2014, 634:44-47. [http://dx.doi.org/10.1016/j.gene.2013.10.032]. 10.1016/j.gene.2013.10.032.
16. Ch Xu., Bai R., Zhang D., Li Z., Zhu H., Lai M., et al. Effects of APOA5-1131T/C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis. PLoS One 2013, 8:e56216. 10.1371/journal.pone.0056216.
17. Wilson P.W.F., Schaefer E.J., Larson M.G., Ordovas J.M. Apolipoprotein E alleles and risk of coronary disease: a meta analysis. Arterioscler Thromb Vasc Biol 1996, 16:1250-1255.
18. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J Lipid Res 1992, 33:447-454.
19. Katsuya T., Baba S., Ishikawa K., Mannami T., Fu Y., Inamoto N., et al. Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study. J Hypertens 2002, 20:2017-2021.
20. Sima A., Iordan A., Stancu C. Apolipoprotein E polymorphism - a risk factor for metabolic syndrome. Clin Chem Lab Med 2007, 45:1149-1153.
21. Lee K.S., Jang Y., Chung Y.K., Chung J.H., Oh B.H., Hong C.H. Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly. Arch Gerontol Geriatr 2010, 50:69-72.
22. Ferreira D.C., Costa T.F., Aguiar S.F.L., Marques A.R.S., Ramos S.A., Gomes K.B., et al. Association of Apoliprotein E polymorphisms and metabolic syndrome in subjects with extreme obesity. Clin Chim Acta 2011, 412:1559-1562.
23. Luptakova L., Sivakova D., Cvicelova M., Wsólová L., Danková Z., Michnová A., et al. Power of biomarkers and their relative contributions to metabolic syndrome in Slovak adult women. Ann Hum Biol 2013, 40:132-138.
24. Frances F., Corella D., Sorli J.V., Guillen M., Gonzalez J.I., Portoles O. Validating a rapid method for detecting common polymorphisms in the APOA5 gene by melting curve analysis using LightTyper. Clin Chem 2005, 51:1279-1282.
25. Hsu L.A., Ko Y.L., Chang C.J., Teng M.S., Wu S., Hu C.F. Apolipoprotein A5 gene -1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan. Clin Chem Lab Med 2008, 46:1714-1719.
26. Song K.H., Cha S., Yu S.G., Yu H., Oh S.A., Kang N.S. Association of apolipoprotein A5 gene -1131T>C polymorphism with the risk of metabolic syndrome in Korean subjects. BioMed Res Int 2013, 10.1155/2013/585134.
27. Niculescu L.S., Vladica M., Sima A.V. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome. Biochem Biophys Res Commun 2010, 391:587-591.
28. Kisfali P., Mohas M., Maasz A., Polgar N., Hadarits F., Marko L., et al. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2010, 20:505-511.
29. Horvatovich K., Bokor S., Baráth A., Maász A., Kisfali P., Járomi L., et al. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients. Int J Pediatr Obes 2011, 6:e318-e325.
30. Merkel M., Heeren J. Give me A5 for lipoprotein hydrolysis!. J Clin Invest 2005, 115:2694-2696.
31. Olivieri O., Martinelli N., Bassi A., Trabetti E., Girelli D., Pizzolo F., et al. ApoE ε2/ε3/ε4 polymorphism, ApoCIII/ApoE ratio and metabolic syndrome. Clin Exp Med 2007, 7:164-172.
32. Tao M.H., Liu J.W., LaMonte M.J., Liu J., Wang L., He Y., et al. Different associations of apolipoprotein E polymorphism with metabolic syndrome by sex in an elderly Chinese population. Metab Clin Exp 2011, 60:1488-1496.
33. Bennet A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298:1300-1311.
34. Hubacek J.A., Pitha J., Adamkova Z., Skodova Z., Lanska V., Poledne R. Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population: almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms. Physiol Res 2003, 52:195-200.
35. Chien K.L., Fang W.H., Wen H.C., Lin H.P., Lin Y.L., Lin S.W., et al. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta 2008, 390:56-62.
36. Li Y.Y., Yin R.X., Lai Q.C., Li Y.Y., Yin R.X., Lai C.Q., et al. Association of apolipoprotein A5 gene polymorphisms and serum lipid levels. Nutr Metab Cardiovasc Dis 2011, 21:947-956.
37. Lee M.J., Chien K.L., Chen M.F., Stephenson D.A., Su T.C. Overweight modulates APOE and APOA5 alleles on the risk of severe hypertriglyceridemia. Clin Chim Acta 2013, 416:31-35.
38. Hubacek J.A., Lanska V., Skodova Z., Adamkova V., Poledne R. Sex-specific interaction between APOE and APOA5 variants and determination of plasma lipid levels. Eur J Hum Genet 2008, 16:135-138.